Title |
Nutrition Therapy Issues in Esophageal Cancer
|
---|---|
Published in |
Current Gastroenterology Reports, June 2012
|
DOI | 10.1007/s11894-012-0272-6 |
Pubmed ID | |
Authors |
Keith R. Miller, Matthew C. Bozeman |
Abstract |
Esophageal cancer has traditionally been a disease with poor long term outcomes in terms of both survival and quality of life. In combination with surgical and pharmacologic therapy, nutrition support has been demonstrated to improve patient tolerance of treatment, quality of life, and longterm outcomes. An aggressive multi-disciplinary approach is warranted with nutrition support remaining a cornerstone in management. Historically, nutrition support has focused on adequate caloric provision to prevent weight loss and allow for tolerance of treatment regimens. Alterations in metabolism occur in these patients making their use of available calories inefficient and the future of nutritional support may lie in the ability to alter this deranged metabolism. The purpose of this article is to review the current literature surrounding the etiology, treatment, and role of nutrition support in improving outcomes in esophageal cancer. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 83 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 21 | 25% |
Student > Bachelor | 12 | 14% |
Student > Postgraduate | 7 | 8% |
Student > Doctoral Student | 5 | 6% |
Student > Ph. D. Student | 4 | 5% |
Other | 11 | 13% |
Unknown | 23 | 28% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 35 | 42% |
Nursing and Health Professions | 15 | 18% |
Biochemistry, Genetics and Molecular Biology | 2 | 2% |
Agricultural and Biological Sciences | 2 | 2% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 1% |
Other | 2 | 2% |
Unknown | 26 | 31% |